Χώρα: Σουηδία
Γλώσσα: Σουηδικά
Πηγή: Läkemedelsverket (Medical Products Agency)
kalciumkarbonat; kolekalciferol
2care4 ApS
A12AX
calcium carbonate; cholecalciferol
500 mg/800 IE
Tuggtablett
kolekalciferol 20 mikrog Aktiv substans; sackaros Hjälpämne; xylitol Hjälpämne; glukos, flytande, spraytorkad Hjälpämne; kalciumkarbonat 1250 mg Aktiv substans; natriumlaurilsulfat Hjälpämne
Apotek
Receptbelagt
kombinationer med vitamin D och/eller övriga läkemedel
Avregistrerad
2015-02-03
PACKAGE LEAFLET: INFORMATION FOR THE USER RECIKALC-D FORTE 500 MG/800 IU CHEWABLE TABLETS CALCIUM/CHOLECALCIFEROL (VITAMIN D3) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Recikalc-D forte is and what it is used for 2. What you need to know before you take Recikalc-D forte 3. How to take Recikalc-D forte 4. Possible side effects 5. How to store Recikalc-D forte 6. Contents of the pack and other information 1. WHAT RECIKALC-D FORTE IS AND WHAT IT IS USED FOR Recikalc-D forte is used to prevent and treat calcium and vitamin D 3 deficiency in the elderly, and as an additional treatment in the management of osteoporosis, when a risk of deficiency of calcium and vitamin D 3 is suspected. Recikalc-D forte contains calcium and vitamin D 3 which both are important components for the formation of bone. Vitamin D 3 regulates the uptake and metabolism of calcium as well as the incorporation of calcium in bone tissue. Ask your doctor, pharmacist or other health personal if you have further questions and always follow their instructions. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE RECIKALC-D FORTE DO NOT TAKE RECIKALC-D FORTE - if you have hypercalcaemia (increased levels of calcium in the blood) or hypercalciuria (increased levels in the urine). - if you have kidney stones - if you have calcium depositions in the kidneys - if you have hypervitaminosis D (increased levels of vitamin D in the blood). - if you have severely impaired kidney function/kidney failure - if you are allergic to calcium, cholecalc Διαβάστε το πλήρες έγγραφο
1 SUMMARY OF THE PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Recikalc-D forte 500 mg/ 800 IU chewable tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each chewable tablet contains calcium carbonate equivalent to 500 mg calcium, cholecalciferol (Vitamin D3) 800 IU (20 microgram). Excipients with known effect: glucose 200 mg and sucrose 1.8 mg. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Chewable tablet White to off white, round, engraved R 152 on one side, diameter 17 mm. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prevention and treatment of calcium and vitamin D deficiency in the elderly. Vitamin D and calcium supplement in addition to specific osteoporosis treatment of patients who are at risk of vitamin D and calcium deficiency. Recikalc-D forte chewable tablets is indicated in adults aged 18 years and over. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults and older people_ One chewable tablet (500 mg/800 IU) daily. The amount of calcium in Recikalc-D forte is less than the usually recommended daily intake. Recikalc - D forte is therefore primarily to be used by patients with need of D-vitamin substitution but with a dietary intake of calcium of 500 mg-1000 mg per day. The patients dietary intake of calcium should be estimated by the prescriber. _Patients with hepatic impairment_ No dose adjustment is required. _Patients with renal impairment_ Recikalc-D forte should not be used in patients with severe renal impairment (see section 4.3). _Paediatric population_ There is no relevant use of Recikalc-D forte chewable tablets in children or adolescents. Method of administration 2 Tablet can be chewed or slowly melted in the mouth. 4.3 CONTRAINDICATIONS Hypercalciuria and hypercalcaemia and diseases and/or conditions which lead to hypercalcaemia and/or hypercalciuria (e.g. myeloma, bone metastases, primary hyperparathyroidism). Nephrolithiasis. Nephrocalcinosis. Hypervitaminosis D. Severe renal impairment and renal failure. Hype Διαβάστε το πλήρες έγγραφο